TRLV Stock — Trulieve Cannabis Corp.

Trulieve Cannabis Corp. (TRLV)

Updated October 16, 2026.

TRLV is a Stock. Total return is 9.2% over the past 0.5 years, 2.4 points ahead of SPY at 6.8%.

Trulieve Cannabis Corp. operates as a cannabis retailer in the United States, cultivating, processing, and manufacturing cannabis products sold under multiple brands through dispensaries in eight states and via home delivery, along with cultivation and processing facilities across several states. The company does not currently have an established distribution schedule. This stock may appeal to investors seeking exposure to the cannabis retail sector.

TRLV performance versus SPY

Price and return data through 2026-10-16.

Total return is 9.2% over the past 0.5 years, 2.4 points ahead of SPY at 6.8%.

TRLV key facts

Asset type

Stock

Asset class

Equity

Inception date

05/04/2026

Distribution frequency

None

Last close

$10.01 (as of 2026-10-16)

Market cap

$1,703,290,749

Average volume

925600.0

Beta

1.805

Payout ratio

0.0%

Forward P/E

22.8833

EPS

$-2.40

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

Who may consider TRLV — and who may not

It is a weaker fit for investors who need monthly cash flow (TRLV does not currently distribute). This is educational context, not a recommendation to buy or sell.

More on TRLV

• All tickers starting with T

Tagged: Pharmaceutical.

Frequently asked questions